"Ann Intern Med"[journal] 检索结果

1501. Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery.

作者: Maura Marcucci.;Kumar Balasubramanian.;P J Devereaux.
来源: Ann Intern Med. 2023年176卷11期eL230324页

1502. Trauma-Informed.

作者: William E Rosa.
来源: Ann Intern Med. 2023年176卷11期1561-1562页

1503. Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism.

作者: Yuzuru Ohshiro.
来源: Ann Intern Med. 2023年176卷11期eL230279页

1504. Missed Directives.

作者: Mitchel L Galishoff.
来源: Ann Intern Med. 2023年176卷11期eL230357页

1505. Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism.

作者: Carolyn D Seib.;Calyani Ganesan.;Manjula Kurella Tamura.
来源: Ann Intern Med. 2023年176卷11期eL230280页

1506. Prevalence of Pharmacologic and Nonpharmacologic Pain Management Therapies Among Adults With Chronic Pain-United States, 2020.

作者: S Michaela Rikard.;Andrea E Strahan.;Kristine M Schmit.;Gery P Guy.
来源: Ann Intern Med. 2023年176卷11期1571-1575页

1507. Acupuncture for Chronic Spontaneous Urticaria.

作者: Mike Cummings.
来源: Ann Intern Med. 2023年176卷12期1674-1675页

1508. Breast Cancer Screening and Prevention.

作者: Amy H Farkas.;Ann B Nattinger.
来源: Ann Intern Med. 2023年176卷11期ITC161-ITC176页

Breast cancer is the most common cancer among U.S. women and its incidence increases with age. Endogenous estrogen exposure, proliferative benign breast disease, breast density, and family history may also indicate increased risk for breast cancer. Early detection with screening mammography reduces breast cancer mortality, but the net benefits vary by age. Assessing a patient's individual breast cancer risk can guide decisions regarding breast cancer screening. All women benefit from healthy behaviors which may reduce breast cancer risk. Some women at increased risk for breast cancer may benefit from risk-reducing medications. Use of screening measures remains suboptimal, especially for uninsured women.

1509. Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy.

作者: Myron S Cohen.;Elizabeth R Brown.
来源: Ann Intern Med. 2023年176卷12期1672-1673页

In their article, Edelstein and colleagues provide the results of an observational study of virologic response in patients who received treatment with nirmatrelvir–ritonavir (N-R) versus those who received no COVID-19 therapy. The editorialists discuss the findings and emphasize the need for further consideration of the dosage, timing, and duration of treatment to inform optimal use of N-R.

1510. Efficacy of Acupuncture for Chronic Spontaneous Urticaria : A Randomized Controlled Trial.

作者: Hui Zheng.;Xian-Jun Xiao.;Yun-Zhou Shi.;Lei-Xiao Zhang.;Wei Cao.;Qian-Hua Zheng.;Feng Zhong.;Ping-Sheng Hao.;Ying Huang.;Ming-Ling Chen.;Wei Zhang.;Si-Yuan Zhou.;Yan-Jun Wang.;Chuan Wang.;Li Zhou.;Xiao-Qin Chen.;Zuo-Qin Yang.;Zi-Hao Zou.;Ling Zhao.;Fan-Rong Liang.;Ying Li.
来源: Ann Intern Med. 2023年176卷12期1617-1624页

The effectiveness of acupuncture for patients with chronic spontaneous urticaria (CSU), reported in a few small-scale studies, is not convincing.

1511. Impact of Clinical Demands on the Educational Mission in Hospital Medicine at 17 Academic Medical Centers : A Qualitative Analysis.

作者: Vishruti Patel.;Angela Keniston.;Lauren McBeth.;Sagarika Arogyaswamy.;Catherine Callister.;Khooshbu Dayton.;Neelam Mistry.;Sarah Mann.;Marisha Burden.
来源: Ann Intern Med. 2023年176卷11期1526-1535页

Clinical growth is outpacing the growth of traditional educational opportunities at academic medical centers (AMCs).

1512. SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study.

作者: Gregory E Edelstein.;Julie Boucau.;Rockib Uddin.;Caitlin Marino.;May Y Liew.;Mamadou Barry.;Manish C Choudhary.;Rebecca F Gilbert.;Zahra Reynolds.;Yijia Li.;Dessie Tien.;Shruti Sagar.;Tammy D Vyas.;Yumeko Kawano.;Jeffrey A Sparks.;Sarah P Hammond.;Zachary Wallace.;Jatin M Vyas.;Amy K Barczak.;Jacob E Lemieux.;Jonathan Z Li.;Mark J Siedner.
来源: Ann Intern Med. 2023年176卷12期1577-1585页

Data are conflicting regarding an association between treatment of acute COVID-19 with nirmatrelvir-ritonavir (N-R) and virologic rebound (VR).

1513. Correction: Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes.

来源: Ann Intern Med. 2023年176卷12期1688页

1514. Web Exclusive. Annals On Call - Malaria in the United States.

作者: Robert M Centor.;Davidson H Hamer.;Ralph Huits.
来源: Ann Intern Med. 2023年176卷11期eA220021页

1515. Conversations About Obesity and Weight: Good News We Can Use.

作者: Christina C Wee.;John E Cornell.
来源: Ann Intern Med. 2023年176卷11期1546-1547页

1516. Relationship Between Clinician Language and the Success of Behavioral Weight Loss Interventions : A Mixed-Methods Cohort Study.

作者: Charlotte Albury.;Helena Webb.;Elizabeth Stokoe.;Sue Ziebland.;Constantinos Koshiaris.;Joseph J Lee.;Paul Aveyard.
来源: Ann Intern Med. 2023年176卷11期1437-1447页

International guidelines recommend that primary care clinicians recognize obesity and offer treatment opportunistically, but there is little evidence on how clinicians can discuss weight and offer treatment in ways that are well received and effective.

1517. Colonoscopy-Ascertained Prevalence of Advanced Neoplasia According to Fecal Hemoglobin Concentration in a Large Cohort of Fecal Immunochemical Test-Negative Screening Participants.

作者: Tobias Niedermaier.;Thomas Heisser.;Rafael Cardoso.;Michael Hoffmeister.;Hermann Brenner.
来源: Ann Intern Med. 2023年176卷11期1569-1571页

1518. Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists.

作者: Ryan J Jalleh.;Karen L Jones.;Michael Nauck.;Michael Horowitz.
来源: Ann Intern Med. 2023年176卷11期1542-1543页

1519. In ischemic LV dysfunction, adding PCI to medical therapy did not reduce a composite of death or aborted sudden death.

作者: Richard G Bach.
来源: Ann Intern Med. 2023年176卷11期JC122页

Perera D, Morgan HP, Ryan M, et al; REVIVED-BCIS2 Investigators. Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: prespecified analyses from the REVIVED-BCIS2 trial. Circulation. 2023;148:862-871. 37555345.

1520. In adults with BMI ≥27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk.

作者: Mayer B Davidson.
来源: Ann Intern Med. 2023年176卷11期JC129页

Garvey WT, Frias JP, Jastreboff AM, et al; SURMOUNT-2 investigators. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402:613-626. 37385275.

结果排序

文献格式

出版时间

出版类型

出版语言